Sugen (SUGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sugen (SUGN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (470)	6/12/1999 11:03:00 PM
From: John McCarthy	Read Replies (3) of 550

Pardon me for jumping in .... I do not own SUGN. I do own QLTI. The following is a paragraph from THIS MONDAY'S Investors Business Daily. It can be found on PAGE 2, top Right Corner. It may or may not be pertinent to what you have been discussing ..... It says .... EYE DRUG HELPS DIABETES, MACULAR DEGENERATION It completely stopped the growth of abnormal blood vessels on or beneath the retinas of laboratory mice, said John Hopkins and Novartis' CIBA Vision eye-care scientists. This could mean people at risk for blindness associated with the illnesses may one day just pop a pill to prevent blinding blood vessel growth. Vessels that grow abnormally in the eyes can leak fluid or blood, causing rapid and server vision loss. Human trials of the drug, called *** PKC 412 *** , could begin early next year. "This is the first drug I've seen that has a knock-your-socks-off kind of effect" said Hopkins researcher Peter A. Campochiaro. End of Article ............. Would someone on this board please post me if you have determined WHICH COMPANY has this drug. Thank you. Regards, John McCarthy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next